MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...
Panelists discuss how academic centers can use telehealth programs like Project ECHO to train community neurologists and ensure consistent, evidence-based MS care across diverse geographic regions.
Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...
During Multiple Sclerosis Awareness Month, UC Riverside experts highlight breakthrough research and expanding treatments ...
Modern disease-modifying drugs (DMTs) have revolutionized the treatment of relapsing-remitting multiple sclerosis (MS). However, their use during pregnancy has long been concerning. A study published ...
Considering the CLARITY Phase III study results, cladribine tablets may offer several improvements over existing MS drugs including a simple, short-course annual dosing regimen of either 2 or 4 weeks ...
Central Illinois Proud on MSN
Multiple sclerosis awareness month: How the disease affects people in Central Illinois
Multiple Sclerosis Awareness Month is a time to recognize those affected by the disease and the treatments available to ...
Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results